The presence of sexually transmitted diseases (STDs) in women increases susceptibility to sexual transmission of HIV and over 300 million people worldwide are estimated to have STDs. The long-term goal of our research is to develop an animal model of HIV vaginal infection and use it to study how STDs increase susceptibility to HIV infection. The model will also be useful for evaluating the efficacy of microbicides in preventing HIV infection as well as studies of mucosal anti-HIV immunity. The specific goals of this innovation grant application are to develop a murine HIV vaginal infection model using mice transgenic (Tg) for human CD4, CCR5 and cyclin T1 and use the model to determine if a pre-existing infection by herpes simplex virus type-2 (HSV-2) increases susceptibility to subsequent infection by HIV. HSV-2 is an especially appropriate STD to study because it is well-documented to increase susceptibility to HIV infection and it is highly prevalent. In addition, there is an extensive supportive literature on HSV-2 vaginal infection in mice. This proof-of-concept study will establish if the Tg mice can be used as a model for sexual transmission of HIV and if HSV-2 pre-infection increases HIV infection in this model. Mice will be infected with HIV capable of only a single round of infection, which has the advantages of facilitating identification of the initial targets of HIV infection and providing a substantially reduced biohazard. HIV infection will be measured by detection of HIV DNA and appearance of green fluorescence protein-positive cells.
In Aim 1 we will determine if intravaginal infection of Tg mice with HIV results in detectable HIV infection and if a pre-existing HSV-2 infection, either acute or latent, affects susceptibility to HIV infection.
In Aim 2, we will determine the effect of HSV-2 infection on the trafficking of HIV-infected cells to lymphoid tissue and the replication state and phenotype of HIV-infected cells. This revised application includes new data that shows infection of Tg mice by HIV can be detected both in vitro and in vivo thus indicating the feasibility of the proposed experiments.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21AI065308-02
Application #
7347566
Study Section
AIDS-associated Opportunistic Infections and Cancer Study Section (AOIC)
Program Officer
Sharma, Usha K
Project Start
2007-02-01
Project End
2009-01-31
Budget Start
2008-02-01
Budget End
2009-01-31
Support Year
2
Fiscal Year
2008
Total Cost
$217,782
Indirect Cost
Name
Rush University Medical Center
Department
Type
DUNS #
068610245
City
Chicago
State
IL
Country
United States
Zip Code
60612
Zariffard, M Reza; Saifuddin, Mohammed; Finnegan, Alison et al. (2009) HSV type 2 infection increases HIV DNA detection in vaginal tissue of mice expressing human CD4 and CCR5. AIDS Res Hum Retroviruses 25:1157-64
Harwani, Sailesh C; Lurain, Nell S; Zariffard, M Reza et al. (2007) Differential inhibition of human cytomegalovirus (HCMV) by toll-like receptor ligands mediated by interferon-beta in human foreskin fibroblasts and cervical tissue. Virol J 4:133
Klempner, Mark S; Wormser, Gary H; Wade, Karen et al. (2005) A case-control study to examine HLA haplotype associations in patients with posttreatment chronic Lyme disease. J Infect Dis 192:1010-3
Wormser, Gary P; Kaslow, Richard; Tang, Jianming et al. (2005) Association between human leukocyte antigen class II alleles and genotype of Borrelia burgdorferi in patients with early lyme disease. J Infect Dis 192:2020-6
Fleming, R V; Marques, A R; Klempner, M S et al. (2004) Pre-treatment and post-treatment assessment of the C(6) test in patients with persistent symptoms and a history of Lyme borreliosis. Eur J Clin Microbiol Infect Dis 23:615-8
Kaplan, R F; Trevino, R P; Johnson, G M et al. (2003) Cognitive function in post-treatment Lyme disease: do additional antibiotics help? Neurology 60:1916-22
McDowell, John V; Sung, Shian-Ying; Hu, Linden T et al. (2002) Evidence that the variable regions of the central domain of VlsE are antigenic during infection with lyme disease spirochetes. Infect Immun 70:4196-203
Weinstein, Arthur; Britchkov, Michael (2002) Lyme arthritis and post-Lyme disease syndrome. Curr Opin Rheumatol 14:383-7
Lin, B; Kidder, J M; Noring, R et al. (2001) Differences in synovial fluid levels of matrix metalloproteinases suggest separate mechanisms of pathogenesis in Lyme arthritis before and after antibiotic treatment. J Infect Dis 184:174-80
Klempner, M S; Hu, L T; Evans, J et al. (2001) Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 345:85-92

Showing the most recent 10 out of 16 publications